Understanding and Calculating Steady State Pharmacokinetics BlogKnowledge Base Understanding and Calculating Steady State Pharmacokinetics Steady state pharmacokinetics can seem abstract and confusing. Read this blog to gain a better…Certara2026 年 3 月 5 日
Model-Based Meta-Analysis of Objective Response Rate and Survival Endpoints to Compare PD-1 and PD-L1 Treatment Outcomes in Non-Small Cell Lung Cancer Publication Model-Based Meta-Analysis of Objective Response Rate and Survival Endpoints to Compare PD-1 and PD-L1 Treatment Outcomes in Non-Small Cell Lung Cancer This study used model-based meta-analysis (MBMA) to assess how well objective response rate (ORR) predicts…Danielle Pillsbury2026 年 3 月 4 日
ADC First-in-Human (FIH) Dose Selection: Designing FIH Studies for Success Blog ADC 首次人体(FIH)剂量选择:成功设计 FIH 研究的关键 Optimize ADC First-in-Human Dose Selection with model-informed strategies and exposure–response insights to design safer, more…Certara2026 年 3 月 3 日
Phoenix Roadshow 2026 – Raleigh/Durham Live Events Phoenix Roadshow 2026 – 美国罗利-达勒姆 Certara2026 年 3 月 2 日
Embracing Model-Informed Drug Discovery: The Path to Better Clinical Outcomes Blog 拥抱模型引导的药物发现:通往更佳临床疗效之路 We cover the evidence of biosimulation improving clinical success rates, making the case for model-informed…Certara2026 年 2 月 27 日
Phoenix Roadshow 2026 – Radnor (Philadelphia area) Live Events Phoenix Roadshow 2026 – Radnor (Philadelphia area) Certara2026 年 2 月 27 日
Formulate Faster: A Purpose-Built Toolkit for Bioequivalence (Phoenix IVIVC Toolkit) On-Demand Webinar Formulate Faster: A Purpose-Built Toolkit for Bioequivalence (Phoenix IVIVC Toolkit) This webinar introduces the Phoenix IVIVC Toolkit, showing how to perform BE analysis and build…Certara2026 年 2 月 27 日
Maximizing the Impact of Antibody–Drug Conjugates (ADCs): Model-Informed Labeling, Expansion, and Market Access Webinar Maximizing the Impact of Antibody–Drug Conjugates (ADCs): Model-Informed Labeling, Expansion, and Market Access Danielle Pillsbury2026 年 2 月 23 日
Optimal Dosing, Optimal Outcomes: Model-Based Approaches for Antibody–Drug Conjugates (ADCs) Webinar Optimal Dosing, Optimal Outcomes: Model-Based Approaches for Antibody–Drug Conjugates (ADCs) Certara2026 年 2 月 23 日